MASSACHUSETTS
-
How to Cope with Loss? Grief Therapist Shares her Sister's Cancer Story
Gray Dove Press presents a deeply touching memoir of love and loss, as two sisters walk a perilous path that takes them to the edge of life. ARLINGTON, Mass., June 6, 2022 /PRNewswire/ -- A new book f…
-
Byrna Technologies Announces Preliminary Second Quarter Revenues of $11.5 Million.
Reiterates Full Year Revenue Guidance of $55-$60 Million ANDOVER, Mass., June 6, 2022 /PRNewswire/ -- Byrna Technologies Inc. (NASDAQ: BYRN) ("Byrna" or "the Company") today announced preliminary reve…
-
IDC Names OneView a Major Player for Worldwide Point-of-Sale Software Vendors
OneView innovation highlighted in the 2022 worldwide point-of-sale software grocery and food store retail vendor assessment. BOSTON, June 6, 2022 /PRNewswire/ -- OneView Commerce today announced that.…
-
Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform
Through real-time metabolite monitoring, Bitome's technology is expected to support accelerated product development timelines across Ginkgo's portfolio of cell programs BOSTON, June 6, 2022 /PRNewswir…
-
Akamai Launches New Malware Protection for Uploaded Files
Edge-based solution detects and blocks malicious files uploaded to web apps and APIs CAMBRIDGE, Mass., June 6, 2022 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that pow…
-
Aspen Aerogels, Inc. Provides Business Update
Accelerated Capital Investments Driven by EV Thermal Barrier Demand; Updated 2022 Financial Outlook NORTHBOROUGH, Mass., June 6, 2022 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the…
-
Haemonetics Corporation Announces Additional Information Regarding Its Investor Day on June 29, 2022
BOSTON, June 6, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has posted its full lineup of speakers planned for the Company's Investor Day, to be hosted in Boston on Wednesday, June 29, 20…
-
Jacobio Announces Phase I Clinical Data of KRAS G12C Inhibitor JAB-21822 at 2022 ASCO Annual Meeting
BEIJING and SHANGHAI and BOSTON, June 5, 2022 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced the phase I clinical data of KRAS G12C inhibitor JAB-21822 at the 2022 annual meeting of American Socie…
-
Curis Announces Encouraging Emavusertib Data at the 2022 American Society of Clinical Oncology Annual Meeting (ASCO)
TakeAim Lymphoma data for the combination of emavusertib plus ibrutinib show tumor reduction in 8 of 9 evaluable patients, including 2 complete responses and 2 partial responses Potential for overcomi…
-
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., June 3, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-st…
-
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., June 3, 2022 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherap…
-
NanoMosaic Partners with BrickBio to Increase its Neurology Content with Novel Tau (Phospho-Thr217) Antibody
BOSTON, June 3, 2022 /PRNewswire/ -- NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, is increasing its capabilities in neurology companion d…
-
Akebia Therapeutics to Present at Jefferies Healthcare Conference
CAMBRIDGE, Mass., June 3, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today an…
-
T1D Exchange to Highlight New Real-World Findings Across 18 Presentations at the American Diabetes Association 82nd Scientific Sessions
– Company showcases breadth of capabilities and commitment to advancing health equity through diverse, compelling type 1 diabetes research –– Oral presentation on "Inequities in Glycemic Outcomes for…
-
Ardelyx to Present at the Jefferies 2022 Healthcare Conference
WALTHAM, Mass., June 3, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines…
-
ASCENT AEROSYSTEMS SPIRIT PLATFORM JOINS DIU BLUE UAS APPROVED LIST
Beginning immediately, any U.S. government customer can buy and operate a Spirit without further technical review or approval. WILMINGTON, Mass., June 2, 2022 /PRNewswire/ -- The Defense Innovation Un…
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., June 2, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted…
-
Azenta to Participate in the Jefferies Healthcare Conference
CHELMSFORD, Mass., June 2, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Healthcare Conference in New York City, on Thursda…
-
Ginkgo Bioworks Announces Participation in William Blair's 42nd Annual Growth Stock Conference
BOSTON, June 2, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in William Blair's 4…
-
Rec. Cannabis Dispensary Essex Apothecary Poises to Open -- Public Celebration Scheduled
LYNN, Mass., June 2, 2022 /PRNewswire/ -- Woman-owned, woman-run cannabis dispensary Essex Apothecary poises to open, announcing public celebration, and offering customized cannabis experiences to cus…